Paul Tudor Jones’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-357,000
Closed -$18.4M 3031
2022
Q3
$18.4M Buy
+357,000
New +$14.8M 0.4% 21

Other funds holding CCXI

Paul Tudor Jones's CCXI Position: Q4 2022 in Review

Paul Tudor Jones sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 357,000 shares — an estimated $18.4M sold.

Paul Tudor Jones first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $18.4M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Paul Tudor Jones reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 357,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $18.4M.
  • Paul Tudor Jones first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Paul Tudor Jones's ChemoCentryx, Inc. position peaked at $18.4M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.